Description

BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited (Scrip Code: 536565) effective March 9, 2026, issued on a preferential basis pursuant to conversion of warrants.

Summary

BSE has notified trading members that 4,00,000 new equity shares of Novelix Pharmaceuticals Limited (Scrip Code: 536565) are listed and permitted to trade on the Exchange with effect from Monday, March 9, 2026. These shares were issued on a preferential basis to non-promoters pursuant to the conversion of warrants at an issue price of Rs. 20/- per share.

Key Points

  • 4,00,000 equity shares of Rs. 10/- each issued at a premium of Rs. 10/- (issue price Rs. 20/-)
  • Issued to non-promoters on a preferential basis via conversion of warrants
  • Shares rank pari-passu with existing equity shares of the company
  • Distribution numbers: 17215001 to 17615000
  • ISIN: INE314I01036
  • All 4,00,000 shares are subject to lock-in until September 30, 2026

Regulatory Changes

No regulatory changes. This is a standard listing notification for newly allotted securities.

Compliance Requirements

  • Trading members must note the lock-in restriction: all 4,00,000 shares (Dist. Nos. 17215001 to 17615000) are locked in until September 30, 2026 and cannot be traded until that date.
  • Trading in these securities is permitted only from March 9, 2026 onwards, subject to the applicable lock-in constraints.

Important Dates

  • Date of Allotment: January 19, 2026
  • Trading Commencement Date: March 9, 2026 (Monday)
  • Lock-in Expiry Date: September 30, 2026

Impact Assessment

This listing adds 4,00,000 equity shares to the tradeable float of Novelix Pharmaceuticals Limited, though all shares are under lock-in until September 30, 2026. The immediate tradeable supply remains unchanged. Post lock-in expiry, the additional shares may exert marginal dilutive pressure. Overall market impact is minimal given the small size of the allotment and the company’s small-cap profile.

Impact Justification

Routine listing of new equity shares from preferential allotment via warrant conversion for a small-cap company; limited broader market impact.